Bruker (BRKR) Non-Current Deferred Tax Liability (2010 - 2025)
Bruker's (BRKR) quarterly Non-Current Deferred Tax Liability came in at $112.5 million in Q4 2025, down 5.06% on a YoY basis from $118.5 million in Q4 2024, and down 5.06% quarter-over-quarter from $118.5 million in Q4 2024.
Analysis
Bruker (BRKR) Non-Current Deferred Tax Liability (2010 - 2025) Analysis & Trends
Bruker (BRKR) has reported Non-Current Deferred Tax Liability for 16 consecutive years, with $112.5 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Deferred Tax Liability fell 5.06% year-over-year to $112.5 million; the trailing twelve-month figure through Dec 2025 stood at $112.5 million (down 5.06% YoY), and the FY2025 full-year result was $112.5 million, down 5.06% from the prior year.
- Non-Current Deferred Tax Liability slipped to $112.5 million in Q4 2025 per BRKR's latest filing, from $118.5 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $178.5 million in Q2 2024 and bottomed at $46.0 million in Q4 2021.
- Historically, Non-Current Deferred Tax Liability has averaged $105.7 million across 5 years, with a median of $97.1 million in 2024.
- The sharpest annual moves came in 2021 and 2024: Non-Current Deferred Tax Liability sank 50.59% in 2021, then jumped 75.04% in 2024.
- Over 5 years, Non-Current Deferred Tax Liability stood at $46.0 million in 2021, then jumped by 35.43% to $62.3 million in 2022, then rose by 8.67% to $67.7 million in 2023, then soared by 75.04% to $118.5 million in 2024, then declined by 5.06% to $112.5 million in 2025.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $112.5 million, $118.5 million, and $178.4 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 112.50 Mn |
| Dec 31, 2024 | 118.50 Mn |
| Sep 30, 2024 | 178.40 Mn |
| Jun 30, 2024 | 178.50 Mn |
| Mar 31, 2024 | 81.80 Mn |
| Dec 31, 2023 | 67.70 Mn |
| Dec 31, 2022 | 62.30 Mn |
| Dec 31, 2021 | 46.00 Mn |
| Dec 31, 2020 | 93.10 Mn |
| Dec 31, 2019 | 48.80 Mn |
| Dec 31, 2018 | 51.10 Mn |
| Dec 31, 2017 | 24.30 Mn |
| Dec 31, 2016 | 10.10 Mn |
| Dec 31, 2015 | 9.50 Mn |
| Dec 31, 2014 | 17.80 Mn |
| Dec 31, 2013 | 22.60 Mn |
| Dec 31, 2012 | 12.10 Mn |
| Dec 31, 2011 | 23.80 Mn |
| Dec 31, 2010 | 18.80 Mn |